Related content

Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy

By Agirbasli Mehmet  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 1, 2011-07 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Suppression by Exendin(9-39)amide of Glucagon-Like Peptide-1 Insulinotropic Action in Rats Infused with Dimethyl Ester of Succinic Acid

By Cancelas J.   Villanueva-Peñacarrillo M.L.   Valverde I.   Malaisse W.J.  

Endocrine Journal, Vol. 15, Iss. 3, 2001-08 ,pp. : 283-285

Humana Press, Inc

Access to resources Recommend Favorite

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

By Cypryk Katarzyna   Vilsbøll Tina   Nadel Iwona   Smyczynska Joanna   Holst Jens Juul   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 58-62

Informa Healthcare

Access to resources Recommend Favorite

Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of l-glutamic acid in a type 2 diabetes animal model

By Cancelas Jesús   Villanueva-Peñacrrillo María   Valverde Isabel   Malaisse Willy  

Endocrine Journal, Vol. 16, Iss. 2, 2001-11 ,pp. : 113-116

Humana Press, Inc

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite